Metabolic Syndrome

Enrollment Closed:
Study to evaluate the effect of an investigational drug for reducing the risk of major cardiovascular events in abdominally obese patients with multiple risk factors. Subjects must be 55 years of age with abdominal obesity and additional risk factors. Please contact us at 630.734.3485 for additional information if you feel you may qualify.

view all clinical trials >>